StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) company profile

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)

Close on Nov 17, 2026Market cap $88.39MP/E –Yield –

About Stereotaxis

Electromedical & Electrotherapeutic Apparatus, SIC 3845

Stereotaxis designs, manufactures, and markets robotic systems, instruments, and information systems for interventional laboratories. Its proprietary Robotic Magnetic Navigation technology uses computer-controlled magnetic fields to directly steer the working tip of flexible catheters and interventional devices during endovascular procedures. The company primarily focuses on electrophysiology, particularly cardiac ablation procedures to treat arrhythmias, while also developing applications for coronary, neuro, and peripheral interventions. Its product portfolio features the Genesis RMN and GenesisX RMN Systems, Synchrony and SynX cath lab display and connectivity solutions, Odyssey systems, and Map-iT diagnostic catheters. Stereotaxis operates as a single business segment, serving electrophysiologists and hospitals worldwide.

The company's systems have been deployed across more than one hundred hospitals globally, where hundreds of physicians have treated over 150,000 patients and published over 500 clinical studies. Stereotaxis maintains principal executive offices in St. Louis, Missouri, and conducts catheter operations in Rogers, Minnesota.

Summary of the business section of Stereotaxis's latest annual report, written by StockData.

Company profile

Company

Legal name
Stereotaxis, Inc.
Founded
1990
Headquarters
St.Louis, MO
Address
710 N Tucker Blvd, Ste 110 63101
Phone
(314) 678-6100
Employees
131, Dec 31, 2025
Industry
Electromedical & Electrotherapeutic Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, St. Louis, Missouri

Stock & identifiers

Ticker
STXS
Exchange
NYSE
IPO date
Aug 12, 2004
Shares outstanding
100M, Jul 31, 2026
Public float
$150.30M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-10 reverse, Jul 11, 2012
SEC CIK
1289340
CUSIP
85916J409
ISIN
US85916J4094
FIGI
BBG000PSJBC2
Share class FIGI
BBG001SKC124
LEI
549300KPNOKI02O2ZP21
EIN
94-3120386

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Kimberly R. PeeryChief Financial Officer3,317
Nathan FischelDirector14,401,329
Ross B. LevinDirector621,248
David BenferDirector771,930
Nachum ShamirDirector179,327
Arun Swarup MenawatDirector1,035,560
Myriam CuretDirector435,161
Paul J. IsaacDirector2,883,856

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$64.39K-$2.04M$326.11K$111–
FY2024$62.20K$3.72M$340.17K$112–
FY2023$62.20K-$4.29M$323.80K$85–
FY2022$62.20K-$49.09M$386.76K$33–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryOption awardsIncentive payOtherTotalvs. prior year
David L. Fischel
Chief Executive Officer
$60.00K––$4.39K$64.39K+4%
Kimberly R. Peery
Chief Financial Officer
$232.50K$55.40K$20.00K$18.21K$326.11K-4%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“of December 31, 2025, we had 131 employees, 40 of whom were engaged directly in research and development, 47 in sales and marketing activities,”

Corporate history

Events identified from SEC filings

See a number that looks wrong?